Prognostic Factor in the Patients With Benign Prostatic Hyperplasia Who Undergo Holmium Laser Enucleation of the Prostate
Completed
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Registration Number
- NCT03460873
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Prognostic factor in the patients with benign prostatic hyperplasia (BPH) who undergo holmium laser enucleation of the prostate
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 432
Inclusion Criteria
- Male patient scheduled to undergo prostatectomy using holmium laser
Read More
Exclusion Criteria
- Urethral stricture, large bladder diverticulum, bladder neck contracture
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of IPSS(International Prostate Symptom Score) changes pre-operation and post-operation (3month, 6month) Complete the questionnaire(IPSS) before and after the treatment
- Secondary Outcome Measures
Name Time Method changes of voided urine volume pre-operation and post-operation (3month, 6month) Comparison of voided urine volume
Occurrence of adverse event post-operation (3month, 6month) collection of adverse event
changes of residual urine volume pre-operation and post-operation (3month, 6month) Comparison of residual urine volume
Trial Locations
- Locations (1)
Samsung Medical Center, Sungkyunkwan University School of Medicine
🇰🇷Seoul, Korea, Republic of